-
Dacomitinib
-
N-(3-chloro-4-fluorophenyl)-7-Methoxy-6-nitroquinazolin-4-aMine
-
N-(3-chloro-4-fluorophenyl)-7-Methoxy-6-aminoquinazolin-4-aMine
-
Entrectinib;N-(5-(3,5-difluorobenzyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1-yl)-2-((tetrahydro-2H-pyran-4-yl)amino)benzamide
-
4-(4-methylpiperazin-1-yl)-2-[(tetrahydropyran-4-yl)(2,2,2-trifluoroacetyl)amino]benzoic acid fluoroacetate
-
5-(3,5-difluoro-benzyl)-1H-indazol-3-ylamine
-
N-[5-(3,5-difluorobenzyl)-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-[(tetrahydropyran-4-yl)-(2,2,2-trifluoroacetyl)amino]benzamide
-
Dabrafenib
-
N-{3-[5-(2-chloro-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1 ,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide
-
N-(3-(2-(2-chloropyriMidin-4-yl)acetyl)-2-fluorophenyl)-2,6-difluorobenzenesulfonaMide
-
Methyl 3-(((2,6-difluorophenyl)sulfonyl)amino)-2-fluorobenzoate
-
2-chloro-4-methylpyrimidine
-
2,2,2-Dimethylthiopropionamide
-
LOXO-292
-
Pyrazolo[1,5-a]pyridine-3-carbonitrile, 4-[6-(3,6-diazabicyclo[3.1.1]hept-3-yl)-3-pyridinyl]-6-(2-hydroxy-2-methylpropoxy)-
